MX9605400A - Tetrapeptidos novedosos, su preparacion y uso. - Google Patents
Tetrapeptidos novedosos, su preparacion y uso.Info
- Publication number
- MX9605400A MX9605400A MX9605400A MX9605400A MX9605400A MX 9605400 A MX9605400 A MX 9605400A MX 9605400 A MX9605400 A MX 9605400A MX 9605400 A MX9605400 A MX 9605400A MX 9605400 A MX9605400 A MX 9605400A
- Authority
- MX
- Mexico
- Prior art keywords
- manufacture
- compounds
- tetrapeptides
- novel
- novel tetrapeptides
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Se describen compuestos de la formula (Ver Formula) en donde R1, R2, R3 y R4 tienen el significado señalado en al descripcion, y un proceso para prepararlos. Los compuestos son adecuados como material de partida para sintetizar substancias que son activas contra tumores.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4415998A DE4415998A1 (de) | 1994-05-06 | 1994-05-06 | Neue Tetrapeptide, ihre Herstellung Verwendung |
| PCT/EP1995/001576 WO1995030690A1 (de) | 1994-05-06 | 1995-04-26 | Neue tetrapeptide, ihre herstellung und verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9605400A true MX9605400A (es) | 1997-12-31 |
Family
ID=6517454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9605400A MX9605400A (es) | 1994-05-06 | 1995-04-26 | Tetrapeptidos novedosos, su preparacion y uso. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US5886147A (es) |
| EP (1) | EP0804466B1 (es) |
| JP (1) | JP4452329B2 (es) |
| KR (1) | KR970702879A (es) |
| AT (1) | ATE174035T1 (es) |
| AU (1) | AU2408295A (es) |
| CA (1) | CA2189691C (es) |
| DE (2) | DE4415998A1 (es) |
| ES (1) | ES2126279T3 (es) |
| FI (1) | FI119641B (es) |
| HU (1) | HU220862B1 (es) |
| MX (1) | MX9605400A (es) |
| WO (1) | WO1995030690A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010009901A1 (en) | 1996-12-11 | 2001-07-26 | Basf Aktiengesellschaft Germany | Antineoplastic peptides |
| TW474946B (en) * | 1995-12-15 | 2002-02-01 | Basf Ag | Novel compounds, the preparation and use thereof |
| EP1229934B1 (en) | 1999-10-01 | 2014-03-05 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| US6203412B1 (en) * | 1999-11-19 | 2001-03-20 | Chartered Semiconductor Manufacturing Ltd. | Submerge chemical-mechanical polishing |
| KR20020066476A (ko) * | 2001-02-12 | 2002-08-19 | 쥬가이 세이야쿠 가부시키가이샤 | 펩타이드 유도체의 제조방법 |
| KR20130009760A (ko) | 2010-02-10 | 2013-01-23 | 이뮤노젠 아이엔씨 | Cd20 항체 및 이의 용도 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4978744A (en) * | 1989-01-27 | 1990-12-18 | Arizona Board Of Regents | Synthesis of dolastatin 10 |
| US4879278A (en) * | 1989-05-16 | 1989-11-07 | Arizona Board Of Regents | Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15 |
| JP3523253B2 (ja) * | 1992-05-20 | 2004-04-26 | アボット ゲーエムベーハー ウント カンパニー カーゲー | ドラスタチン誘導体 |
| DE4415997A1 (de) * | 1994-05-06 | 1995-11-09 | Basf Ag | Neuer peptidischer Wirkstoff und dessen Herstellung |
-
1994
- 1994-05-06 DE DE4415998A patent/DE4415998A1/de not_active Withdrawn
-
1995
- 1995-04-26 AU AU24082/95A patent/AU2408295A/en not_active Abandoned
- 1995-04-26 CA CA2189691A patent/CA2189691C/en not_active Expired - Fee Related
- 1995-04-26 WO PCT/EP1995/001576 patent/WO1995030690A1/de not_active Ceased
- 1995-04-26 HU HU9603068A patent/HU220862B1/hu unknown
- 1995-04-26 DE DE59504450T patent/DE59504450D1/de not_active Expired - Lifetime
- 1995-04-26 MX MX9605400A patent/MX9605400A/es unknown
- 1995-04-26 ES ES95917962T patent/ES2126279T3/es not_active Expired - Lifetime
- 1995-04-26 JP JP52863895A patent/JP4452329B2/ja not_active Expired - Fee Related
- 1995-04-26 AT AT95917962T patent/ATE174035T1/de active
- 1995-04-26 US US08/737,279 patent/US5886147A/en not_active Expired - Lifetime
- 1995-04-26 EP EP95917962A patent/EP0804466B1/de not_active Expired - Lifetime
-
1996
- 1996-11-05 FI FI964446A patent/FI119641B/fi not_active IP Right Cessation
- 1996-11-06 KR KR1019960706260A patent/KR970702879A/ko not_active Withdrawn
-
1998
- 1998-12-15 US US09/211,013 patent/US6248865B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE4415998A1 (de) | 1995-11-09 |
| WO1995030690A1 (de) | 1995-11-16 |
| AU2408295A (en) | 1995-11-29 |
| JP4452329B2 (ja) | 2010-04-21 |
| ES2126279T3 (es) | 1999-03-16 |
| CA2189691C (en) | 2011-02-15 |
| HUT75709A (en) | 1997-05-28 |
| US5886147A (en) | 1999-03-23 |
| DE59504450D1 (de) | 1999-01-14 |
| ATE174035T1 (de) | 1998-12-15 |
| CA2189691A1 (en) | 1995-11-16 |
| EP0804466A1 (de) | 1997-11-05 |
| HU9603068D0 (en) | 1997-01-28 |
| FI119641B (fi) | 2009-01-30 |
| KR970702879A (ko) | 1997-06-10 |
| FI964446L (fi) | 1997-01-03 |
| US6248865B1 (en) | 2001-06-19 |
| FI964446A0 (fi) | 1996-11-05 |
| EP0804466B1 (de) | 1998-12-02 |
| JPH09512802A (ja) | 1997-12-22 |
| HU220862B1 (en) | 2002-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9709240A (es) | Fenilpiridazinonas. | |
| GB9013091D0 (en) | Process for the production of methanol synthesis gas | |
| HUT56558A (en) | Process for producing oxetanones | |
| EP0886638A4 (en) | IMPROVED PROCESS FOR THE SYNTHESIS OF OLIGOMER COMPOUNDS | |
| MY107819A (en) | Preparation of substituted piperidines. | |
| FI972391A0 (fi) | Amiinipolyolireaktiotuotteen sisältävä sideainekoostumus | |
| MY116364A (en) | Anthracyclinone derivatives, their synthesis and their use in treating pathological disorders associated with amyloidosis. | |
| PL336640A1 (en) | Substituted 3,3-diamino-2- propenonitriles, their production and application | |
| JO2249B1 (en) | A compound of 6.3-dialkyl-6.5-dihydro-4-hydroxy-biran-2-one | |
| MX9605400A (es) | Tetrapeptidos novedosos, su preparacion y uso. | |
| CA2176144A1 (en) | Anthracycline derivatives for treatment of amyloidosis | |
| IN187760B (es) | ||
| HUT54708A (en) | Process for producing tigogenine-beta-cellobiozide | |
| MX9701569A (es) | Pirimidin(tio)onas substituidas. | |
| UA35556C2 (uk) | Спосіб одержання гідрокортизону та проміжні сполуки в синтезі гідрокортизону | |
| AU3259997A (en) | Ring-fused dihydropyranes, process for the preparation and use thereof | |
| MXPA02001406A (es) | Heterociclilos-2h-cromenos substituidos. | |
| AU665710B2 (en) | Process for the production of synthesis gas | |
| MX9603087A (es) | Procedimiento para la obtencion de aminocarboniltriazolinonas substituidas. | |
| BG105247A (en) | N-substituted azabicycloheptane derivatives, production and use thereof | |
| WO2000011951A3 (de) | Verwendung von 5-amino-pyrazol-derivaten zur bekämpfung von mikrooranismen | |
| NZ332245A (en) | Substituted benzo-oxazolol carboxylic acid derivatives, process for their production and medicaments containing them | |
| MX9801130A (es) | Tiamacrolidos. | |
| ZA924888B (en) | Process for the synthesis of enantiomers of 3-aminochroman compounds | |
| PL346003A1 (en) | N-substituted azabicycloheptane derivatives, production and use thereof |